Navigation Links
Bracken to Become Chairman of HCA's Board of Directors Effective Dec. 15
Date:11/2/2009

NASHVILLE, Tenn., Nov. 2 /PRNewswire/ -- HCA has announced that Richard M. Bracken will become chairman of HCA's board of directors, effective December 15, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050825/CLTH069LOGO )

Bracken will replace Jack O. Bovender, Jr., 64, who will retire from the company, effective that same date. In addition, R. Milton Johnson, HCA's chief financial officer and executive vice president, was elected to the board of directors, also effective December 15, 2009.

"Richard has been an invaluable asset to HCA, and his years in both hospital management and executive leadership with the company provide him with a keen understanding of strategic operations and an appreciation for its culture," said Bovender. "I could not envision a better successor or a more qualified guardian of our company's legacy."

Bracken, 57, has served as president and chief executive officer of HCA since January 1, 2009, and has served as a director of the company since 2002. He was president and chief operating officer from January 2002 to January 2009. A veteran of more than 30 years in the hospital industry, Bracken has been a member of HCA's executive leadership for most of his career, and has held positions at the facility, division, and group levels within the organization.

Johnson, 52, has served 27 years with the company, holding positions as head of HCA's Tax Department and as Controller, before being named CFO and executive vice president in July of 2004.

"Milton is an outstanding addition to our board," said Bracken. "His extensive understanding of the company's financial operations and history of leadership within HCA make him particularly qualified to serve as a director."

HCA and its affiliates operate 163 hospitals and 105 ambulatory surgery centers in 20 states and
'/>"/>

SOURCE HCA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
3. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
4. Family of Three Americans Become Pain Free and Improve Their Quality of Life With Stem Cell Treatment in Mexico
5. Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
6. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
7. Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimers Drug After Flurizans Discontinuation
8. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
9. Fora Care Group Becomes Pioneering Educational Member of the International Society of Vascular Health
10. Baxa Announces IntelliFlowRx(TM) to Become DoseEdge(TM) Dose Management System
11. Sequenom Announces Paul Maier to Become Interim Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015  Delays in ... projects can slow down the decision-making process, resulting ... therefore, absolutely critical for biopharmaceutical companies to develop ... approval process for quicker and more meaningful insights. ... Best Practices, LLC, nearly three-quarters of benchmarked study ...
(Date:8/28/2015)... 2015 Research and ... of the "12th Annual Report and Survey ... to their offering. The 2015 12th ... and Production is the most recent study of ... projected future capacity and production. The report contains ...
(Date:8/28/2015)... 28, 2015 Research ... of the "Investigation Report on China,s Insulin ... Developed by Novo Nordisk, insulin aspart ... important drug for the treatment of diabetes. Compared ... acting insulin analog, starts working fast and reports ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 212th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
... issued today a shareholders, letter discussing the results of its fiscal ... Dear Imagenetix shareholder - Following ... we commence the new fiscal year, I would like to address ...   Over the past few years our primary strategy ...
... July 12, 2011 Arena Pharmaceuticals, Inc. (NASDAQ: ... 1 clinical trial of APD811, an orally bioavailable agonist ... treatment of pulmonary arterial hypertension, or PAH. ... tolerability and pharmacokinetics of 0.03 mg, 0.05 mg, 0.1 ...
Cached Medicine Technology:Imagenetix, Inc. Discusses March 31, 2011 Fiscal Year End Results and Future Focus 2Imagenetix, Inc. Discusses March 31, 2011 Fiscal Year End Results and Future Focus 3Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension 4
(Date:8/29/2015)... ... 2015 , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, the Director of ... will present an educational program titled “Asbestos and Your Health.” , The two and ... open at 6:45pm) at Calvary United Methodist Church, 16 E Park Ave., Ambler, PA ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made possible ... lives of patients, according to a newly published report. Surviving Mesothelioma has more ... article. , The authors of the new paper focus on several types ...
(Date:8/29/2015)... York, NY (PRWEB) , ... August 29, 2015 , ... ... unofficial end of summer (which astronomically, officially ends on September 22nd this year). For ... summer-induced cyber security hangovers linger on which could prove far more costly than a ...
(Date:8/29/2015)... ... August 29, 2015 , ... Hamstring strain ... stretching, soft tissue manipulation. Platelet rich plasma injections also have mixed results. ... improve treatment outcomes. This localized treatment seems to address the symptoms and ...
(Date:8/28/2015)... ... , ... Rio Salado College joined nine educational institutions in Washington ... the EDUCAUSE - Next Generation Learning Challenges 2015 Breakthrough Models Incubator funded by the ... Models Incubator hosted by EDUCAUSE and NGLC, which is designed to bring leadership ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4
... , MONDAY, Jan. 10 (HealthDay News) -- The ... how to create a vaccine that can protect people against ... that people who were infected with the H1N1 virus and ... against a wide variety of flu strains. The virus ...
... By Amanda Gardner HealthDay Reporter , MONDAY, ... path through Rep. Gabrielle Giffords, brain on Saturday will likely ... point how extensive that damage might be. However, doctors ... Arizona congresswoman immediately after the shooting are already encouraged by ...
... is a highly subjective experience. We each have a pain ... A paper in the International Journal of Behavioural and ... pain in research. There are many chronic illnesses and ... because of the subjectivity in a patient,s reporting of their ...
... type of skin cancer. In this paper, Leif Ellisen and ... and p73 in SCC cells, and discovered a feedback loop ... SCC, they found that inhibiting one of these miRs decreased ... highlighting a new potential therapeutic target. , Squamous cell carcinoma ...
... researchers have found that a protein that plays an important ... due to additional mechanisms that cause it to promote atherosclerosis, ... the January issue of the journal Arteriosclerosis, Thrombosis and ... why some antioxidant therapies have not yielded more positive results. ...
... change during the 20th century in England and Wales in ... features in Alcohol and Alcoholism . While deaths ... the early part of the century, the pattern changed so ... lower social classes by the end of the century. ...
Cached Medicine News:Health News:People Who Recovered From H1N1 Offer Clues to Better Vaccine 2Health News:While Doctors Are Optimistic, Prognosis for Wounded Congresswoman Is Unclear 2Health News:While Doctors Are Optimistic, Prognosis for Wounded Congresswoman Is Unclear 3Health News:While Doctors Are Optimistic, Prognosis for Wounded Congresswoman Is Unclear 4Health News:Does it hurt? 2Health News:Protein thought to protect against oxidative stress also promotes clogging of arteries 2Health News:Social class and changes in mortality from liver cirrhosis over the 20th Century 2
Provides exceptional resolution and fundus scanning capability. Excellent for small pupil diagnosis and treatment....
... 20D diagnostic/laser lens is perfectly corrected ... coma delivering the best retinal ... on the market. Its advanced double ... magnification and perfect image clarity across ...
The 15D provides high magnification along with an optimized working distance from the cornea. With its 4.11x magnification it is also well suited for disc and macular observation....
... The NIDEK MK-2000 ... performance in a wide ... MK-2000 utilizes single-use, ultra-sharp ... Blades are supplied sterile ...
Medicine Products: